Eton Pharmaceuticals (ETON) Enterprise Value (2017 - 2025)

Eton Pharmaceuticals has disclosed Enterprise Value across 9 years of filings, most recently posting -$25.9 million for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$25.9 million, down 73.69% year-over-year; the trailing twelve-month figure through Dec 2025 was -$25.9 million (down 73.69% YoY), and the FY2025 annual result was -$25.9 million, down 73.69% from the prior year.
• Enterprise Value came in at -$25.9 million for Q4 2025 at Eton Pharmaceuticals, up from -$37.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$13.4 million in Q3 2022 to a low of -$37.1 million in Q3 2025.
• The 5-year median for Enterprise Value is -$19.0 million (2024), against an average of -$20.3 million.
• Across the five-year window, Enterprise Value slumped 209.72% in 2021 and surged 41.09% in 2022, its largest moves.
• Eton Pharmaceuticals' Enterprise Value stood at -$14.4 million in 2021, then retreated by 13.18% to -$16.3 million in 2022, then plunged by 31.17% to -$21.4 million in 2023, then jumped by 30.17% to -$14.9 million in 2024, then sank by 73.69% to -$25.9 million in 2025.
• The last three Enterprise Value figures came in at -$25.9 million (Q4 2025), -$37.1 million (Q3 2025), and -$25.4 million (Q2 2025), per Business Quant data.